Driehaus Capital Management LLC Legend Biotech Corp Transaction History

Driehaus Capital Management LLC

  • $9.27 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$57.25 - $69.74 $1.61 Million - $1.96 Million
28,103 Added 13.64%
234,206 $14.1 Million
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $13 Million - $15.8 Million
206,103 New
206,103 $13.8 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $55.0 $10.6 Million - $17.4 Million
317,117 New
317,117 $17.4 Million
Q3 2020

Nov 16, 2020
SELL
$27.5 - $39.61 $10 Million - $14.5 Million
-365,174 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$36.1 - $42.56 $13.2 Million - $15.5 Million
365,174 New
365,174 $15.5 Million

Others Institutions Holding LEGN

# of Institutions
205
Shares Held
74.5M
Call Options Held
371K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email